{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:54:55Z","timestamp":1790704495854,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00392-022-02065-4","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:02:56Z","timestamp":1658116976000},"page":"1276-1285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry"],"prefix":"10.1007","volume":"111","author":[{"given":"Vivian","family":"Vij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Piayda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Nelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Gloekler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Galea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"F\u00fcrholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabit","family":"Arzamendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Asmarats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Freixa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Flores-Umanzor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Sondergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Nombela-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"McInerney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Korsholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Zeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Operhalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Guedeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Iriart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelie","family":"Miton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gilhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egzon","family":"Veliqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Meincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nordbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitrii","family":"Ognerubov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Merkulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Cruz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Gonzalez-Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Laricchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mangieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyder","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Wilko","family":"Schrickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Rodes-Cabau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-1056","authenticated-orcid":false,"given":"Alexander","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"2065_CR1","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","volume":"41","author":"D Hildick-Smith","year":"2020","unstructured":"Hildick-Smith D, Landmesser U, Camm AJ et al (2020) Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study. Eur Heart J 41:2894\u20132901. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa169","journal-title":"Eur Heart J"},{"key":"2065_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG et al (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534\u2013542. https:\/\/doi.org\/10.1016\/S0140-6736(09)61343-X","journal-title":"Lancet"},{"key":"2065_CR3","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/ehjci\/jey010","volume":"19","author":"H Cochet","year":"2018","unstructured":"Cochet H, Iriart X, Sridi S et al (2018) Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study. Eur Heart J Cardiovasc Imaging 19:1351\u20131361. https:\/\/doi.org\/10.1093\/ehjci\/jey010","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2065_CR4","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F et al (2018) Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol 71:1528\u20131536. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.076","journal-title":"J Am Coll Cardiol"},{"key":"2065_CR5","doi-asserted-by":"publisher","first-page":"E216","DOI":"10.1002\/ccd.27135","volume":"92","author":"M Lempereur","year":"2018","unstructured":"Lempereur M, Aminian A, Saw J (2018) Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv 92:E216\u2013E217. https:\/\/doi.org\/10.1002\/ccd.27135","journal-title":"Catheter Cardiovasc Interv"},{"key":"2065_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2016.05.006","author":"A Sedaghat","year":"2016","unstructured":"Sedaghat A, Schrickel J, Andri\u00e9 R et al (2016) Thrombus formation after left atrial appendage occlusion with the amplatzer amulet device. JACC Clin Electrophysiol. https:\/\/doi.org\/10.1016\/j.jacep.2016.05.006","journal-title":"JACC Clin Electrophysiol"},{"key":"2065_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR et al (2018) Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation 138:874\u2013885. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035090","journal-title":"Circulation"},{"key":"2065_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.29458","author":"A Sedaghat","year":"2021","unstructured":"Sedaghat A, Nickenig G, Schrickel JW et al (2021) Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. https:\/\/doi.org\/10.1002\/ccd.29458","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"2065_CR9","doi-asserted-by":"publisher","first-page":"E1288","DOI":"10.4244\/EIJ-D-20-00886","volume":"16","author":"X Freixa","year":"2021","unstructured":"Freixa X, Cepas-Guillen P, Flores-Umanzor E et al (2021) Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion. EuroIntervention 16:E1288\u2013E1294. https:\/\/doi.org\/10.4244\/EIJ-D-20-00886","journal-title":"EuroIntervention"},{"key":"2065_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/circinterventions.120.010195","author":"A Sedaghat","year":"2021","unstructured":"Sedaghat A, Vij V, Al-Kassou B et al (2021) Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry. Circ Cardiovasc Interv. https:\/\/doi.org\/10.1161\/circinterventions.120.010195","journal-title":"Circ Cardiovasc Interv"},{"key":"2065_CR11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jcin.2019.02.003","volume":"12","author":"A Aminian","year":"2019","unstructured":"Aminian A, Schmidt B, Mazzone P et al (2019) Incidence, characterization, and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER amulet observational study. JACC Cardiovasc Interv 12:1003\u20131014. https:\/\/doi.org\/10.1016\/j.jcin.2019.02.003","journal-title":"JACC Cardiovasc Interv"},{"key":"2065_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.117.005997","volume":"11","author":"R Pracon","year":"2018","unstructured":"Pracon R, Bangalore S, Dzielinska Z et al (2018) Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy. Circ Cardiovasc Interv 11:1\u20137. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005997","journal-title":"Circ Cardiovasc Interv"},{"key":"2065_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","volume":"78","author":"T Simard","year":"2021","unstructured":"Simard T, Jung RG, Lehenbauer K et al (2021) Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol 78:297\u2013313. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.098","journal-title":"J Am Coll Cardiol"},{"key":"2065_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jcin.2013.02.014","volume":"6","author":"B Plicht","year":"2013","unstructured":"Plicht B, Konorza TFM, Kahlert P et al (2013) Risk factors for thrombus formation on the amplatzer cardiac plug after left atrial appendage occlusion. JACC Cardiovasc Interv 6:606\u2013613. https:\/\/doi.org\/10.1016\/j.jcin.2013.02.014","journal-title":"JACC Cardiovasc Interv"},{"key":"2065_CR15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/eurheartj\/ehaa803","volume":"42","author":"HN Rashid","year":"2021","unstructured":"Rashid HN, Layland J (2021) Association between device-related thrombus and the neo-appendage with left-atrial appendage occlusion devices. Eur Heart J 42:1047\u20131048. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa803","journal-title":"Eur Heart J"},{"key":"2065_CR16","doi-asserted-by":"publisher","first-page":"968.e13","DOI":"10.1016\/j.cjca.2019.12.036","volume":"36","author":"J Mill","year":"2020","unstructured":"Mill J, Olivares AL, Arzamendi D et al (2020) Impact of flow dynamics on device-related thrombosis after left atrial appendage occlusion. Can J Cardiol 36:968.e13-968.e14. https:\/\/doi.org\/10.1016\/j.cjca.2019.12.036","journal-title":"Can J Cardiol"},{"key":"2065_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.118.006360","volume":"11","author":"B Meier","year":"2018","unstructured":"Meier B (2018) What lies beneath left atrial appendage occlusion. Circulation 11:1\u20133. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.006360","journal-title":"Circulation"},{"key":"2065_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","volume":"12","author":"L S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard L, Wong YH, Reddy VY et al (2019) Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN. JACC Cardiovasc Interv 12:1055\u20131063. https:\/\/doi.org\/10.1016\/j.jcin.2019.04.004","journal-title":"JACC Cardiovasc Interv"},{"key":"2065_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008481","volume":"13","author":"G Duthoit","year":"2020","unstructured":"Duthoit G, Silvain J, Marijon E et al (2020) Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study. Circ Cardiovasc Interv 13:e008481. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.008481","journal-title":"Circ Cardiovasc Interv"},{"key":"2065_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/openhrt-2020-001326","volume":"7","author":"P Garot","year":"2020","unstructured":"Garot P, Iriart X, Aminian A et al (2020) Value of FEops HEARTguide patient-specific computational simulations in the planning of left atrial appendage closure with the Amplatzer Amulet closure device: rationale and design of the PREDICT-LAA study. Open Hear 7:1\u20135. https:\/\/doi.org\/10.1136\/openhrt-2020-001326","journal-title":"Open Hear"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02065-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T22:03:08Z","timestamp":1667253788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02065-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02065-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alexander Sedaghat has received travel grants from Abbott and Boston Scientific and is a proctor for Lifetech. Lars Sondergaard has received consultant fees and institutional research grants from Abbott and Boston Scientific, and is shareholder in Eclipse Medical. Dr Cruz-Gonzalez is a proctor for Abbott, Boston Scientific and Lifetech and was funded by ISCIII (PI19\/00658) and co-funded by ERDF, \"A way to make Europe\". Jens Erik Nielsen-Kudsk is a proctor and consultant for Abbott and Boston Scientific. Dabit Arzamendi is a proctor for Abbott and Boston Scientific. Xavier Freixa is a proctor for Abbott, Boston Scientific and Lifetech. Antonio Mangieri is part of the advisory board of Boston Scientific and received an institutional grant from Boston Scientific. Dr. Nombela-Franco has served as a proctor of Abbott Vascular and received speaker honoraria from Boston Scientific and Abbott Vascular. Dr. Meier has received consultant fees from Abbott. Xavier Iriart is a proctor for Abbott and Boston Scientific. Dr. Deepak L. Bhatt discloses the following relationships - Advisory Board: AngioWave, Bayer, Boehringer Ingelheim, Cardax, CellProthera, Cereno Scientific, Elsevier Practice Update Cardiology, High Enroll, Janssen, Level Ex, McKinsey, Medscape Cardiology, Merck, MyoKardia, NirvaMed, Novo Nordisk, PhaseBio, PLx Pharma, Regado Biosciences, Stasys; Board of Directors: AngioWave (stock options), Boston VA Research Institute, Bristol Myers Squibb (stock), DRS.LINQ (stock options), High Enroll (stock), Society of Cardiovascular Patient Care, TobeSoft; Chair: Inaugural Chair, American Heart Association Quality Oversight Committee; Consultant: Broadview Ventures; Data Monitoring Committees: Acesion Pharma, Assistance Publique-H\u00f4pitaux de Paris, Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott), Boston Scientific (Chair, PEITHO trial), Cleveland Clinic (including for the ExCEED trial, funded by Edwards), Contego Medical (Chair, PERFORMANCE 2), Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine (for the ENVISAGE trial, funded by Daiichi Sankyo; for the ABILITY-DM trial, funded by Concept Medical), Novartis, Population Health Research Institute; Rutgers University (for the NIH-funded MINT Trial); Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Chair, ACC Accreditation Oversight Committee), Arnold and Porter law firm (work related to Sanofi\/Bristol-Myers Squibb clopidogrel litigation), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim; AEGIS-II executive committee funded by CSL Behring), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Canadian Medical and Surgical Knowledge Translation Research Group (clinical trial steering committees), Cowen and Company, Duke Clinical Research Institute (clinical trial steering committees, including for the PRONOUNCE trial, funded by Ferring Pharmaceuticals), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), K2P (Co-Chair, interdisciplinary curriculum), Level Ex, Medtelligence\/ReachMD (CME steering committees), MJH Life Sciences, Oakstone CME (Course Director, Comprehensive Review of Interventional Cardiology), Piper Sandler, Population Health Research Institute (for the COMPASS operations committee, publications committee, steering committee, and USA national co-leader, funded by Bayer), Slack Publications (Chief Medical Editor, Cardiology Today\u2019s Intervention), Society of Cardiovascular Patient Care (Secretary\/Treasurer), WebMD (CME steering committees), Wiley (steering committee); Other: Clinical Cardiology (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Patent: Sotagliflozin (named on a patent for sotagliflozin assigned to Brigham and Women's Hospital who assigned to Lexicon; neither I nor Brigham and Women's Hospital receive any income from this patent.) Research Funding: Abbott, Acesion Pharma, Afimmune, Aker Biomarine, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CSL Behring, Eisai, Ethicon, Faraday Pharmaceuticals, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Merck, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Reid Hoffman Foundation, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, 89Bio; Royalties: Elsevier (Editor, Braunwald\u2019s Heart Disease); Site Co-Investigator: Abbott, Biotronik, Boston Scientific, CSI, Endotronix, St. Jude Medical (now Abbott), Philips, SpectraWAVE, Svelte, Vascular Solutions; Trustee: American College of Cardiology; Unfunded Research: FlowCo, Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}